CAPITAL ADJUSTMENT INFORMATION - 20.01.2021:Das Instrument I97 CA13740H1001 CANDENTE GOLD CORP. EQUITY wird cum Kapitalmassnahme gehandelt am 19.01.2021 und ex Kapitalmassnahme am 20.01.2021
The instrument I97 CA13740H1001 CANDENTE GOLD CORP. EQUITY is traded cum capital adjustment on 19.01.2021 and ex capital adjustment on 20.01.2021
CAPITAL ADJUSTMENT INFORMATION - 20.01.2021:Das Instrument DP2A US26140E6005 DPW HOLDINGS INC. DL-,001 EQUITY wird cum Kapitalmassnahme gehandelt am 19.01.2021 und ex Kapitalmassnahme am 20.01.2021
The instrument DP2A US26140E6005 DPW HOLDINGS INC. DL-,001 EQUITY is traded cum capital adjustment on 19.01.2021 and ex capital adjustment on 20.01.2021
CAPITAL ADJUSTMENT INFORMATION - 19.01.2021:Das Instrument JP3436170009 SOFTBRAIN CO. LTD. EQUITY wird ex Kapitalmassnahme gehandelt am 19.01.2021
The instrument JP3436170009 SOFTBRAIN CO. LTD. EQUITY is traded ex capital adjustment on 19.01.2021
CAPITAL ADJUSTMENT INFORMATION - 19.01.2021:Das Instrument VGG008271246 ADAMAS FINANCE ASIA LTD EQUITY wird ex Kapitalmassnahme gehandelt am 19.01.2021
The instrument VGG008271246 ADAMAS FINANCE ASIA LTD EQUITY is traded ex capital adjustment on 19.01.2021
CAPITAL ADJUSTMENT INFORMATION - 20.01.2021:Das Instrument 1NP SE0008966295 INDEX PHARM. AB AK B O.N. EQUITY wird cum Kapitalmassnahme gehandelt am 19.01.2021 und ex Kapitalmassnahme am 20.01.2021
The instrument 1NP SE0008966295 INDEX PHARM. AB AK B O.N. EQUITY is traded cum capital adjustment on 19.01.2021 and ex capital adjustment on 20.01.2021
CAPITAL ADJUSTMENT INFORMATION - 19.01.2021:Das Instrument MY0 CA62848M1077 MYCONIC CAPITAL CORP. EQUITY wird ex Kapitalmassnahme gehandelt am 19.01.2021
The instrument MY0 CA62848M1077 MYCONIC CAPITAL CORP. EQUITY is traded ex capital adjustment on 19.01.2021
The instrument I97 CA13740H1001 CANDENTE GOLD CORP. EQUITY is traded cum capital adjustment on 19.01.2021 and ex capital adjustment on 20.01.2021
CAPITAL ADJUSTMENT INFORMATION - 20.01.2021:Das Instrument DP2A US26140E6005 DPW HOLDINGS INC. DL-,001 EQUITY wird cum Kapitalmassnahme gehandelt am 19.01.2021 und ex Kapitalmassnahme am 20.01.2021
The instrument DP2A US26140E6005 DPW HOLDINGS INC. DL-,001 EQUITY is traded cum capital adjustment on 19.01.2021 and ex capital adjustment on 20.01.2021
CAPITAL ADJUSTMENT INFORMATION - 19.01.2021:Das Instrument JP3436170009 SOFTBRAIN CO. LTD. EQUITY wird ex Kapitalmassnahme gehandelt am 19.01.2021
The instrument JP3436170009 SOFTBRAIN CO. LTD. EQUITY is traded ex capital adjustment on 19.01.2021
CAPITAL ADJUSTMENT INFORMATION - 19.01.2021:Das Instrument VGG008271246 ADAMAS FINANCE ASIA LTD EQUITY wird ex Kapitalmassnahme gehandelt am 19.01.2021
The instrument VGG008271246 ADAMAS FINANCE ASIA LTD EQUITY is traded ex capital adjustment on 19.01.2021
CAPITAL ADJUSTMENT INFORMATION - 20.01.2021:Das Instrument 1NP SE0008966295 INDEX PHARM. AB AK B O.N. EQUITY wird cum Kapitalmassnahme gehandelt am 19.01.2021 und ex Kapitalmassnahme am 20.01.2021
The instrument 1NP SE0008966295 INDEX PHARM. AB AK B O.N. EQUITY is traded cum capital adjustment on 19.01.2021 and ex capital adjustment on 20.01.2021
CAPITAL ADJUSTMENT INFORMATION - 19.01.2021:Das Instrument MY0 CA62848M1077 MYCONIC CAPITAL CORP. EQUITY wird ex Kapitalmassnahme gehandelt am 19.01.2021
The instrument MY0 CA62848M1077 MYCONIC CAPITAL CORP. EQUITY is traded ex capital adjustment on 19.01.2021